Tag: Shenzhen Hepalink

Kymab bags £18m investment for antibodies

by Selina McKee | Nov 29, 2016 | News | 0

UK monoclonal antibody biopharma Kymab has secured funds of £81 million via a round of Series C financing.

Read More

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN

E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999